Medical Policy

D-1004-003

Policy Id

HHO-DE-MP-1004

Topic

Bariatric Surgery

Section

Surgery

Effective Date

Jun 16, 2025

Issued Date

May 16, 2025

Last Revision Date

05/2025

Annual Review

05/2026

Prepared By

J Fletcher

DISCLAIMER

Highmark medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions.

POLICY STATEMENT

This policy provides information regarding the coverage of, as determined by applicable federal and/or state legislation. 

This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records.

The qualifications of the policy will meet the standards of the National Committee for Quality Assurance (NCQA) and the Delaware Department of Health and Social Services (DHSS) and all applicable state and federal regulations. 

Policy Position

Prior Authorization

Prior Authorization may be required. Please validate codes on the Prior Authorization Lookup Tool https://www.highmarkhealthoptions.com/providers/prior-auth-lookup

Procedures

Prior authorization is required.

The policy is applicable at the time surgery is requested. BMI and weight requirements apply at the time of the initial consultation with the bariatric surgeon.

The following bariatric procedures may be considered medically necessary for the surgical treatment of morbid obesity when ALL of the selection criteria are met. Bariatric surgery should be performed in appropriately selected individuals by surgeons who are adequately trained and experienced in the specific techniques used and in institutions that support a comprehensive bariatric surgery program, including long-term monitoring and follow-up post-surgery.  

Laparoscopic adjustable gastric banding using an FDA-approved adjustable gastric band is a second-tier procedure that should ONLY be performed when extenuating circumstances exist.

 

Selection Criteria for Adults

Bariatric surgery may be considered medically necessary for individuals aged 18 or over when ALL of the following criteria are met

·       The procedure is ONE or more of the following

o   Biliopancreatic bypass with duodenal switch (or open procedure for individuals with a BMI of 50 kg/m2 or greater)

o   Roux-en-Y gastric bypass (RYGB) (laparoscopic or open procedure)

o   Sleeve Gastrectomy (laparoscopic or open procedure)

NOTE: Sleeve gastrectomy is an eligible procedure as a first stage of a two-stage procedure or as a sole definitive procedure. For high BMI individuals in whom the duodenal switch may be difficult, it is reasonable to do a sleeve gastrectomy as the first stage of an intended two-stage duodenal switch. This does permit subsequent assessment of both the efficacy of the sleeve (to see whether the second stage is really needed), assessment of the compliance of the individual (to see whether the more complicated procedure is justified) or to examine the metabolic and nutritional effects of the sleeve (to see whether potential further metabolic derangements of the duodenal switch would make it unadvisable)

o   Laparoscopic adjustable gastric banding using an FDA approved adjustable gastric band when ALL of the following criteria are met

§  A contraindication to biliopancreatic bypass with duodenal switch, Rou-en-Y gastric bypass, and sleeve gastrectomy is documented in the medical record

·       The individual is morbidly obese as defined by ONE or more of the following

o   A weight which is at least 100 lbs. or 100% over ideal weight

o   A BMI of at least 40 kg/m2

o   A BMI of 33 kg/m2 with ONE or more of the following

§  Medically refractory hypertension (blood pressure greater than 140 mmHg systolic and/or 90 mmHg diastolic despite concurrent use of three (3) anti-hypertensive agents of different classes)

§  Cardiovascular heart disease (with objective documentation by exercise stress test, radionuclide stress test, pharmacologic stress test, stress echocardiography, CT angiography, coronary angiography, heart failure or prior myocardial infarction)

§  Coronary heart disease (with objective documentation (by exercise stress test, radionuclide stress test, pharmacologic stress test, stress echocardiography, CT angiography, coronary angiography, heart failure, or prior myocardial infarction)

§  Hyperlipidemia (above 30mg/dl above guideline-directed goal) on maximum doses of monotherapy

§  Diabetes mellitus type II with glycosylated hemoglobin (HbA1C) above 8.0% on one or more medications

§  Obstructive sleep apnea (OSA) (diagnosed by polysomnography showing apnea-hypopnea index of 15 events/hour or more)

§  Obesity-hypoventilation syndrome (OHS)

§  Pickwickian syndrome (a combination of OSA and OHS)

§  Nonalcoholic fatty liver disease (NAFLD)

§  Pseudotumor Cerebri

§  Nonalcoholic steatohepatitis (NASH)

  • The individual has documented failure to respond to conservative measures for weight reduction for a period of at least six (6) consecutive months prior to consideration of bariatric surgery, and these attempts should be reviewed by the practitioner prior to seeking approval for the surgical procedure (Conservative measures include changes to the individual’s dietary and exercise regimen)
  • The individual has completed a multidisciplinary evaluation including medical, nutritional, and psychological evaluations. The individual's medical record documentation should indicate that all psychosocial issues have been identified and addressed
  • The individual understands the procedure and has the ability to participate and comply with life-long follow-up and the life-style changes (e.g., changes in dietary habits, and beginning an exercise program)

If the individual does not meet ALL of the selection criteria for bariatric surgery, the procedure will be denied as not medically necessary.

Bariatric procedures not meeting the criteria as indicated in this policy are considered not medically necessary.

 

Selection Criteria for Adolescents

The eligible bariatric surgical procedures listed above unless otherwise specified are covered for individuals under the age of 18 years when they meet ALL of the following criteria:

  • Attainment or near-attainment of physiologic/skeletal maturity at approximately, age 13 in girls and 15 for boys. (The individual has attained Tanner 4 pubertal development and final or near-final adult height (e.g., 95 % or greater) of adult stature); and
  • The individual is morbidly obese defined as a BMI greater than 50 kg/m2  or severely obese defined as a BMI greater than 40 kg/m2 with ANY ONE or more obesity-related comorbidities:
    • Hypertension; or
    • Insulin resistance; or
    • Glucose intolerance; or
    • Dyslipidemia; or
    • Clinically significant OSA; or  
    • Substantially impaired quality of life or activities of daily living; or
  • A BMI between 35-40 kg/m2 in addition to ONE or more serious obesity related comorbidities:
    • Type II diabetes; or
    • Moderate to severe OSA (apnea-hypopnea index greater than 15); or
    • Pseudotumor cerebri; or
    • NASH; and
  • Individuals should have documented failure to respond to conservative measures for weight reduction prior to consideration of bariatric surgery, and these attempts should be reviewed by the practitioner prior to seeking approval for the surgical procedure. As a result, some centers require active participation in a formal weight reduction program that includes frequent documentation of weight, dietary regimen, and exercise. However, there is a lack of evidence on the optimal timing, intensity and duration of nonsurgical attempts at weight loss, and whether a medical weight loss program immediately preceding surgery improves outcomes; and
  • The individual must complete a psychological evaluation performed by a licensed mental health care professional and be recommended for bariatric surgery. The individual's medical record documentation should indicate that all psychosocial issues have been identified and addressed; and
  • The individual must be able to show decisional capacity and maturity in the psychological evaluation and provide informed assent for surgical management; and
  • The individual must be capable and willing to adhere to nutritional guidelines postoperatively; and
  • The individual must have a supportive and committed family environment; and
  • Selection criteria is a critical process requiring psychiatric evaluation and a multidisciplinary team approach. The individual's understanding of the procedure and ability to participate and comply with life-long follow-up and the life-style changes (e.g., changes in dietary habits, and beginning an exercise program) are necessary to the success of the procedure. 

If the adolescent does not meet ALL of the adolescent selection criteria for bariatric surgery, the procedure will be denied as not medically necessary.

Bariatric procedures not meeting the criteria as indicated in this policy are considered not medically necessary.

Repeat or Revised Bariatric Surgical Procedures

Surgical repair to correct perioperative or late chronic complications of a bariatric procedure may be considered medically necessary when there is documentation of a surgical complication related to the perioperative or late chronic complications of a bariatric procedure. These include but are not limited to:

  • Enteric fistula that does not close with bowel rest and nutritional support; or
  • Gastrogastric fistula associated with ulcers, gastroesophageal reflux disease (GERD) and weight gain; or
  • Band erosion; or
  • Disruption/anastomotic leakage of a suture/staple line; or
  • Tubing leak or port dislocation; or
  • Small bowel obstruction; or
  • Band intolerance with obstructive symptoms (e.g. vomiting, esophageal spasm); or
  • Band slippage and/or prolapse that cannot be corrected with manipulation or adjustment; or
  • Stricture/stenosis with dysphagia, solid food intolerance and/or severe reflux; or
  • Stomal stenosis; or
  • Refractory marginal ulcers; or
  • Non-absorption resulting in hypocalcemia or malnutrition; or
  • Weight loss of 20% or more below ideal body weight. 

Repeat surgical procedures for revision or conversion to another surgical procedure may be considered medically necessary when the initial bariatric surgery was medically necessary (and the individual continues to meet all the medical necessity criteria for bariatric surgery); and when ANY ONE of the following criteria is met:

  • A conversion to a sleeve gastrectomy, RYGB or biliopancreatic bypass with duodenal switch (BPD/DS) for individuals who have not had adequate weight loss success (defined as less than 50% of excess body weight) two (2) years following the primary bariatric surgery procedure and the individual has been compliant with a prescribed nutrition and exercise program following the procedure; or

·         A revision of a primary bariatric surgery procedure that has failed due to dilatation of the gastric pouch, dilated gastrojejunal stoma, or dilation of the gastrojejunostomy (GJ)            anastomosis if the primary procedure was successful in inducing weight loss prior to the dilation of the pouch or GJ anastomosis, and the individual has been compliant with a            prescribed nutrition and exercise program following the procedure; or

·         Replacement of an adjustable band if there are complications (e.g., port leakage, slippage) that cannot be corrected with band manipulation or adjustments; or

·         A conversion from an adjustable band to a sleeve gastrectomy, RYGB or BPD/DS for individuals who have been compliant with a prescribed nutrition and exercise program            following the band procedure and have experienced complications that cannot be corrected with band manipulation, adjustments, or replacement. 

Individual postoperative noncompliance negates the efficacy of revision or conversion surgery.

Conversion or revision surgery is considered not medically necessary when due to inadequate weight loss related to non-compliance with post-operative nutrition and exercise recommendations.

Repeat procedures for repair, revision, or conversion to another surgical procedure following a gastric bypass or gastric restrictive procedure not meeting the criteria as indicated in this policy are considered not medically necessary.

 

The following bariatric procedures are considered experimental/investigational, and therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature.

  • Endoscopic procedures including but not limited to;
    • StomaphyX™ device or restorative obesity surgery (ROSE) procedure; or
    • Aspiration therapy devices; or
    • Endoscopic gastroplasty; or
    • Gastrointestinal Liners (e.g., the EndoBarrier); or
    • Gastric balloons; or
    • Transoral outlet reduction (TORe); or
  • Biliopancreatic bypass (the Scopinaro procedure) or laparoscopic; or
  • The long-limb gastric bypass; or
  • Intestinal bypass; or
  • Laparoscopic gastric plication; or
  • Vagal nerve blocking (VBLOC) therapy (neuromodulation non-metabolic), also known as the Maestro implant or Maestro rechargeable system; or
  • Mini-gastric bypass; or
  • Vertical banded gastroplasty

Post-payment Audit Statement

The medical record must include documentation that reflects the medical necessity criteria and is subject to audit by Highmark Health Options at any time pursuant to the terms of your provider agreement.

 

Place of Service: Inpatient/Outpatient

These procedures may be performed as either an inpatient or outpatient depending upon the individual patient’s condition or comorbidities.

 

REIMBURSEMENT

Participating facilities will be reimbursed per their Highmark Health Options contract. 

CPT code

Description

43644

Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux -en-Y gastroenterostomy (roux limb 150 cm or less).

43645

Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption.

43770

Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric restrictive device (gastric band and subcutaneous port components).

43771

Laparoscopy, surgical, gastric restrictive procedure; revision of adjustable.

43772

Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device component only.

43773

Laparoscopy, surgical, gastric restrictive procedure; removal and replacement of adjustable gastric restrictive device component only.

43774

Laparoscopy, surgical, gastric restrictive procedure; removal of adjustable gastric restrictive device and subcutaneous port components.

43775

Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (e.g., sleeve gastrectomy).

43842

Gastric restrictive procedure, without gastric bypass, for morbid obesity, vertical-banded gastroplasty.

43843

Gastric restrictive procedure, without gastric bypass, for morbid obesity, other than vertical-banded gastroplasty.

43845

Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and i l eoileostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch).

43846

Gastric restrictive procedure, with gastric bypass for morbid obesity with short limb (150 cm or less) Rous-en-Y gastroenterostomy.

43847

;with small intestine reconstruction to limit absorption.

43848

Revision, open, of gastric restrictive procedure for morbid obesity, other than adjustable gastric restrictive device (separate procedure).

43860

Revision of gastrojejunal anastomosis (gastrojejunostomy) with reconstruction, with or without partial gastrectomy or intestine resection; without vagotomy

43886

Gastric restrictive procedure, open, revision of subcutaneous port component only.

43887

Gastric restrictive procedure, open; removal of subcutaneous port component only.

43888

Gastric restrictive procedure, open; removal and replacement of subcutaneous port component only.

Covered Diagnosis Codes for Procedure Codes 43644, 43770, 43775, 43843, and 43846

E66.01

Z68.35

Z68.36

Z68.37

Z68.38

Z68.39

Z68.41

Z68.42

Z68.43

Z68.44

Z68.45

K95.01 K95.09 K95.81
K95.89            

Covered Diagnosis Codes for Procedure Code 43845

E66.01

Z68.43

Z68.44

Z68.45

Noncovered Diagnosis Codes

E66.1

E66.3

E66.9

E66.09

Bariatric Status Code

      Z98.84    

 

References

Aikenhead, A., Knai, C. and Lobstein, T. (2011). Effectiveness and cost-effectiveness of paediatric bariatric surgery: a systematic review. Clinical Obesity, 1: 12-25.doi: 10.1111/j.1758-8111.2010.00003x. . Accessed on February 10, 2016. Accessed on January 10, 2022.

Alexandrou A, Felekouras E, Giannopoulos A, et al. What is the Actual Fate of Super-Morbid-Obese Patients Who Undergo Laparoscopic Sleeve Gastrectomy as the First Step of a Two-Stage Weight-Reduction Operative Strategy? Obes Surg 2012. Accessed on February 10, 2016. Accessed on January 10, 2022.

Action on Smoking and Health Fact Sheet “Smoking and surgery”. March 2014. Accessed February 12, 2016.

American Society for Bariatric Surgery (ASBS). Rationale for the Surgical Treatment of Morbid Obesity. [ASBS Web site]. Original: 11/29/01. (Revised: 11/23/05). Accessed on February 10, 2016.

American Society for Metabolic and Bariatric Surgery (ASMBS) Clinical Issues Committee of the American Society for Metabolic and Bariatric Surgery. Updated Position Statement on Sleeve Gastrectomy as a Bariatric Procedure. [ASMBS Web site]. Revised 10/28/2011. Accessed February 10, 2016.

American Society for Bariatric Surgery (ASBS). Emerging Technologies and Clinical Issues Committees of the ASMBS. American Society for Metabolic and Bariatric Surgery Position Statement on emerging endosurgical interventions for treatment of obesity. [ASBS Web site]. January 2009. Accessed on February 10, 2016.

American College of Obstetricians and Gynecologists (ACOG). Obstet Gynecol.2009; 113:1405-1413. Accessed February 10, 2016.

American Society for Metabolic & Bariatric Surgery. Updated Position Statement on Sleeve Gastrectomy as a Bariatric Procedure. Revised 03/14/2012. [Cited on 01/14/2015]. Accessed on February 11, 2016.

Apers JA, Wens C, van Vlodrop V, et al. Perioperative outcomes of revisional laparoscopic gastric bypass after failed adjustable gastric banding and after vertical banded gastroplasty: experience with 107 cases and subgroup analysis. Surg Endosc. 2012 Sep 26. Accessed on February 10, 2016.

Alqahtani AR, Elahmedi M, Alamri H, et al. Laparoscopic Removal of Poor Outcome Gastric Banding with Concomitant Sleeve Gastrectomy. Obes Surg. 2013 Mar 6. Accessed in February 10, 2016.

Black JA, White B, Viner RM, Simmons RK. Bariatric surgery for obese children and adolescents: a systematic review and meta-analysis. Obes Rev. 2013; 14(8):634-44. Accessed on February 10, 2016.

Brinkley, M. Diet to Help You Lose Weight Before a Gastric Bypass, July 18, 2017. LIVESTRONG.COM. Accessed on November 21, 2017.

Blackburn GL, Hutter MM, Harvey AM, et al. Expert panel on weight loss surgery: Executive report update. Obesity (Silver Spring). 2009; 17(5):842–862.

Chiapaikeo D, Schultheis M, Protyniak, eta al. Analysis of reoperations after laparoscopic adjustable gastric banding. JSLS. 2014; 18(4). Accessed on February 10, 2016.

Cobourn C, Mumford D, Chapman MA, Wells L. Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg. 2010 April; 20(4):415-422. Accessed on February 10, 2016.

Dielen, F., Soeters, P.B., Greve, JW. Laparoscopic Adjustable Gastric Banding versus Open Vertical Banded Gastroplasty: A Prospective Randomized Trial. Obesity Surgery. November 2005. Accessed on November 29, 2017.

Ferreira, L.M. Vertical Banded Gastroplasty: What You Need To Know. Obesity News Today. 2013 -2017. Accessed on November 29, 2017.

Fink JF, Kole KL, Yenumula PR, et al. Predicting risk for serious complications with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2011 Oct; 254(4):633-40. Doi: 10.1097/SLA.0b013e318230058c. Accessed on February 12, 2016.

Foletto M. Sleeve gastrectomy as revisional procedure for failed gastric banding or gastroplasty. Surg Obes Relat Dis. 2010 Mar; 6(2):146-51. Accessed on February 10, 2016.

Hofman, B. (2013). Bariatric surgery for obese children and adolescents: a review of the moral challenges. BMC Medical Ethics, 14:18. doi:10.1186/1472-6939-14-18. Accessed on February 10, 2016. Accessed on January 10, 2022.

International Sleeve Gastrectomy Expert Panel Consensus Statement: best practice guidelines based on experience of 12,000 cases. Surgery for Obesity and Related Diseases. 8 (2012):8-19. Accessed on February 10, 2016

Kehagias, I, Karamanakos, SN, Argentou, M, Kalfarentzos, F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg. 2011 Nov; 21(11):1650-6. PMID: 21818647. Accessed on February 11, 2016.

Keidar A, Hect L, Weiss R. Bariatric surgery in obese adolescents. Curr Opin Clin Nutr Metab Care. 2011; 14(3):286-90. Accessed on February 10, 2016.

Karamanakos, SN, Vagenas, K, Kalfarentzos, F, Alexandrides, TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008 Mar; 247(3):401-7. PMID: 18376181 Accessed on February 11, 2016. Accessed on January 10, 2022.

Mechanick, J.I., Kushner, R.F. Sugerman, H.J., Gonzalez-Compoy, J.M, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIATRIC SURGERY PATIENT. Obesity: A research Journal; Obesity Society; April 2009. Accessed on November 29, 2017.

Mechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., Dixon, J. B. and Brethauer, S. (2013), Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by American association of clinical endocrinologists, The obesity society, and American society for metabolic & bariatric surgery. Obesity, 21: S1–S27. doi: 10.1002/oby.20461. Accessed on February 12, 2016.

Michalsky, M. P., et al. (2015). Cardiovascular risk factors in severely obese adolescents. JAMA Pediatrics. doi:10.1001/jamapediatrics.2014.3690. Accessed on February 10, 2016.

Mognol, P, Chosidow, D, Marmuse, JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005 Aug; 15(7):1030-3. PMID: 16105402. Accessed February 11, 2016.

National Institute for Health and Care Excellence Website “Commissioning a smoking cessation service for people having elective surgery”. Accessed on February 12, 2016.

Nobili, V., et al. (2015). Indications and limitations of bariatric intervention in severely obese children and adolescents with and without non-alcoholic steatohepatitis. Journal of Pediatric Gastroenterology and Nutrition. doi:10.1097/MPG.0000000000000715. Accessed on February 10, 2016.

Nguyen NT, Hohmann S, Slone J, et al. Improved Bariatric Surgery Outcomes for Medicare Beneficiaries After Implementation of the Medicare National Coverage Determination. Arch Surg. 2010; 145(1):72-78. Accessed on February 10, 2016.

Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009; 250(4):631-41. Accessed on February 10, 2016.

Nguyen NT, Longoria M, Gelfand DV, et al. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg. 2005; 15(7):1077-81. Accessed February 10, 2016.

Nguyen NT, Rivers R, Wolfe BM. Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg. 2003; 197(4):548-55. Accessed February 10, 2016.

Peterli, R, Borbely, Y, Kern, B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013 Nov; 258(5):690-4; discussion 5. PMID: 23989054. Accessed on February 11, 2016

Regan, JP, Inabnet, WB, Gagner, M, Pomp, A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003 Dec; 13(6):861-4. PMID: 14738671. Accessed on February 11, 2016.

Sakorafas GH, Milingos D, Peros G. Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci. 2007; 52(5):1313-25. Accessed on February 10, 2016.

Still, C.D., Benotti, P., Wood, G.C. Outcomes of Preoperative Weight Loss in High-Risk Patients Undergoing Gastric Bypass Surgery. Arch Surg, October 1, 2007; 142(10):994-998. Accessed on November 21, 2017.

Sudan, R., Jacobs, D.O. Biliopancreatic Diversion with Duodenal Switch. Surgical Clinics of North America 91(6):1281-93, ix; December 2011. Accessed on November 29, 2017.

Tarantino I, Warschkow R, Steffen T, Bisang P, et al. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg. 2011 Dec; 21(12):1870-8. doi: 10.1007/s11695-011-0495-x. Accessed on February 10, 2016.

Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tobacco Control, 2006; 15: 352–8. Accessed February 12, 2016.

U.S. National Institutes of Health. ClinicalTrials.gov. A Prospective, Randomized Multicenter Study to Evaluate the Safety and Efficacy of the ReShape DuoTM Intragastric Balloon System in Obese Subjects. ClinicalTrials.gov Identifier: NCT01673698. Accessed February 10, 2016.

Vassallo C, Andreoli M, La Manna A, Turpini C. 60 reoperations on 890 patients after gastric restrictive surgery. Obes Surg.2001; 11(6):752-6. Accessed February 10, 2016.

Windover AK. Tobacco use in bariatric patients. Bariatric Times. 2013; 10(1):8-11. Accessed on February 12, 2016.

Wilson JA, Romagnuolo J, Byrne TK, et al. Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroent. 2006; 101:2194–2199.

Winkle, CW. New Research: safety of adolescent bariatric surgery. Theravive. March 11, 2015. Accessed on January 27, 2016.

Zheng Y, Wang M, He S, et al. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med. 2015; 13:246. Accessed on February 10, 2016.

Zellmer, JD, Mathiason, MA, Kallies, KJ, Kothari, SN. Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis. American journal of surgery.